临床研究/肿瘤癌症 40
- 拜登的前列腺癌诊断凸显了筛查和意识的重要性
- 基因组检测可以预测前列腺癌对化疗的耐药性
- 177 Lu-rhPSMA-10.1注射液在mCRPC中显示出阳性辐射剂量测定结果
- FDA授予Detalimogene vorapplant用于高风险NMIBC的RMAT认证
- Botulinum toxin reduces PSMA therapy-related salivary gland toxicity
- 透明细胞肾细胞癌诊断剂试验启动
- The future of OAB treatment: Emerging nerve targets and AI may guide therapy
- FDA扩大Illuccix标签，纳入在紫杉醇前环境中进行RLT的患者选择
- Anne Schuckman医学博士强调了NMIBC有前途的新发展
- FDA greenlights phase 1 trial of theranostic radiopharmaceutical for mCRPC
- CHMP建议欧盟批准达罗鲁米特加ADT用于mHSPC
- CHMP recommends EU approval of darolutamide plus ADT in mHSPC
- 现实世界研究比较了mCSPC中ARPI之间的总生存率
- Real-world studies compare overall survival between ARPIs in mCSPC
- Phase 3 trial launches of ifinatamab deruxtecan vs chemotherapy in mCRPC
- 在mCRPC中启动伊非那他玛德鲁克替康与化疗的3期试验
- FDA approves integrated sacral neuromodulation system for urinary urge incontinence
- 评估ArteraAI对前列腺癌临床决策影响的研究
- Study to evaluate impact of ArteraAI on clinical decision-making for prostate cancer
- Jim Hu，医学博士谈根治性前列腺切除术中GG 1前列腺癌的升级
- Expert discusses differentiating prostate cancer from age-related issues
- FDA does not approve talazoparib plus enzalutamide for non-HRR gene mutated mCRPC
- FDA不批准他拉唑帕利加恩杂鲁胺治疗非HRR基因突变的mCRPC
- Murilo De Almeida Luz, MD, on PSA and ALP changes with enzalutamide/radium-223
- From BCG shortage to scientific surge: Inside the NMIBC treatment renaissance
- 不同mHSPC人群中剩余未满足的需求
- 第三阶段ZIRCON研究的主要结果
- Improving diversity in future clinical trials for mHSPC
- Ruben Olivares, MD, discusses remote robot–assisted HIFU for prostate cancer
- CHAI biomarkers demonstrate prognostic utility for high-grade Ta NMIBC
- 64Cu-SAR-Bombesin shows efficacy in detecting prostate cancer recurrence
- Vignesh Packiam, MD, on choosing between options in NMIBC
- FDA approves mitomycin intravesical solution for recurrent LG-IR-NMIBC
- Strategies to bridge gender disparities in AAS and citations in the oncology literature
- AI-based tool aims to optimize MRI use in prostate cancer diagnosis
- Jad Chahoud，医学博士，一线扎扎林替尼加纳武单抗治疗晚期ccCC
- PSMA-PET成像产品Gozellix在美国市场推出
- Dipen Parekh, M.D. named Chief Executive Officer of the University of Miami Health System
- Stacy Loeb, MD, MSc, PhD (Hon), discusses the nuances of prostate cancer screening
- 二线卡博替尼对晚期肾细胞癌显示出疗效